期刊文献+

青岛地区子宫颈病变组织中人乳头瘤病毒16型L1基因多态性分析 被引量:2

Analysis of HPV16 L1gene variants of different cervical lesions in Qingdao
下载PDF
导出
摘要 目的分析青岛地区不同宫颈病变组织中人乳头瘤病毒(HPV)16型L1基因序列的多态性,探讨其序列变异与宫颈癌的相关性。方法提取2008年6月至2010年5月青岛大学医学院附属医院妇产科61例宫颈癌组织和181例宫颈脱落细胞DNA,采用PCR技术筛选HPV16阳性标本,进而对其L1基因全长进行扩增、测序,应用DNASTAR软件进行序列比对,分析核苷酸和氨基酸的变异。结果慢性宫颈炎组、宫颈上皮内瘤变(CIN)组和宫颈癌组HPV16的感染率分别为30.0%(12/40)、41.1%(58/141)和65.6%(40/61),3组比较,差异有统计学意义(P<0.05)。共有96例成功扩增出HPV16L1基因,慢性宫颈炎、CIN和宫颈癌组扩增率分别为25.0%(10/40)、37.6%(53/141)和54.1%(33/61)。HPV16型L1基因共发现13处变异,宫颈癌组织均发生C6240G、A6432G、6902insATC、6954delGAT及G7061A(无义)5处突变,另一突变热点为A6178C,但其在慢性宫颈炎、CIN、宫颈癌组的频率分布比较,差异无统计学意义(P>0.05)。结论青岛地区HPV16 L1基因的多态性具有地域性,可能导致病毒地方株的免疫原性和抗原性改变,但与宫颈癌的发生发展无明显关系。 Objective To analyze sequence variants of the HPV16late gene L1derived from Qingdao women with different cervical lesions,and to detect the relationship between the sequence variant and the cervical cancer.Methods DNA was extracted from 61cervical cancer biopsies and 181cervical-scraping cell lysate.The full length of L1gene was amplified and sequenced,and the DNASTAR software was used to analyze the variants of nucleotide and acid amino.Results The positive rate of HPV16was 30.0% (12/40),41.1% (58/141)and 65.6% (40/61)in cervicitis,CIN and cervical cancer.The distribution showed statistical difference(P〈0.05).A total of 96samples were amplified successfully in all samples.The rate were 25.0% (10/40),37.6% (53/141)and 54.1% (33/61)in cervicitis,CIN and cervical cancer.A total of 13variants were found in the full length of L1gene.Five mutations,including C6240G,A6432G, 6902insATC,6954delGAT and G7061A (nonsense),were found in all of the positive samples.Mutation of A6178Cwas another hot spot,whose distribution showed no significant difference among cervicitis,CIN and cervical cancer(P〉0.05).Conclusion There are unique feature of the HPV16L1gene variation,which may cause certain changes concerning immunogenicity and antigenicity of the virus,nevertheless has no apparent connection to the development of cervical lesions.
出处 《中国妇产科临床杂志》 2012年第4期274-277,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
基金 青岛市公共领域科技支撑计划项目(11-2-3-1-8-nsh)
关键词 宫颈上皮内瘤变 宫颈癌 人乳头瘤病毒16型 L1基因 突变 cervical intraepithelial neoplasia; human papillomvirus 16; L1gene; mutation
  • 相关文献

参考文献15

  • 1Steben M, Duarte - Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol, 2007, 107 (2 Suppl 1): S2-S5.
  • 2Bernard HU, Calleja-Macias IE, Dunn ST, et al. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer, 2006, 118:1071 - 1076.
  • 3Seedorf K, Krammer G, Durst IVL Human papillomavirus typel6 DNA sequence. Virology, 1985, 145:181 - 185.
  • 4Lee K, Magalhaes I, Clavel C. Human papillomavirus 16 E6, LI, L2 and E2 gene variants in cervical lesion progres- sion. Virus Res, 2008, 131: 106-110.
  • 5Pillai MR, Hariharan R, Janki MB. Molecular variants of HPV- 16 associated with cervical cancer in Indian popula- tion. Int J Cancer, 2009, 125:91 - 103.
  • 6安静,余黎,席亮,白慕群,周旭.人乳头瘤病毒16型L1蛋白的克隆及表达[J].微生物学免疫学进展,2007,35(1):26-29. 被引量:4
  • 7Kirnbauer R, Taub J, Greenstone H, et al. Efficient self- assembly of human papillomavirus type 16 L1 and L1 -L2 in- to virus- like particles. J Virol, 1993, 67:6929 - 6936.
  • 8Varsani A, Williamson AL, Jaffer MA. A deletion and point mutation study of the human papillomavirus type 16 major caDsidgene. Virus Res, 2006, 122: 154-163.
  • 9陈俊,董海艳,朱珊丽,欧琴,张丽芳.温州地方株HPV16型L1基因多态性及蛋白特性分析[J].温州医学院学报,2009,39(6):538-540. 被引量:8
  • 10Pande S, ]ain N, Prusty BK. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control re- gion in biopsy samples from cervical cancer patients in north India. J ClinMicrobiol, 2008, 46.. 1060-1066.

二级参考文献14

  • 1马正海,张富春,梅新娣,马彩玲,刘开江.新疆南部地区维吾尔族妇女宫颈癌组织中人乳头状瘤病毒16型L1基因突变谱分析[J].中华医学杂志,2004,84(12):987-991. 被引量:18
  • 2高慧,黄正芳,徐向明,孙强,殷俊,杨玲,贾筱琴,朱洪,李厚达.扬州地方株HPV16L1基因的克隆及序列分析[J].东南大学学报(医学版),2005,24(1):17-20. 被引量:5
  • 3Das BC,Sharma JK,Gopalakrishna V, et al. A Frequency of human papillomavirus DNA sequences incervical carcinomas of Indian women as revealed by southern blot hybridization and poly merase chain reaction[J].Med Virol, 1992, 36(4):239-245.
  • 4Bosch FX, Manos MM. Munoz N, et al. Prevalence of humanpapillomavirus in cervical cancer:a worldwide prospective[J].Natl Cancer Inst, 1995, 87( 1 ):796-802.
  • 5Icenogle JP, Sathya P, Miller DL, et al. Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16[J]. Virology, 1991, 184(1):101-107.
  • 6Ortiz M, Torres M, Munoz L, et al.Oncogenic Human Papillomavirus (HPV) Type Distribution and HPV Type 16 E6 Variants in Two Spanish Population Groups with Different Levels of HPV Infection Risk [J]. J Clin Microbiol, 2006, 44(4): 1428-1434.
  • 7Pande S,Jain N,Prusty BK, et al. Human Papillomavirus Type 16 Variant Analysis of E6, E7, and L1 Genes and Long Control Region in Biopsy Samples from Cervical Cancer Patients in North India[J].J Clin Microbiol. 2008,46(3):1060- 1066.
  • 8萨姆布鲁克等著;黄培堂等译.分子克隆实验指南[M].第3版.北京:科学出版社,2002:27-30.
  • 9Cornelison TL.Human papillomavirus genotype 16 vaccines for cervical cancer prophylaxis and treatment[J].Current Opinion Oncol 2000,12:466-473.
  • 10Walboomer JM,Jacobs MV.Human papillomavirus is a necessary cause of invasive cervical cancer worldwise[J].J Pathol 1999,189:12.

共引文献10

同被引文献22

  • 1安静,余黎,席亮,白慕群,周旭.人乳头瘤病毒16型L1蛋白的克隆及表达[J].微生物学免疫学进展,2007,35(1):26-29. 被引量:4
  • 2Hickey DK, Patel MV, Fahey JV, et al. Innate and adap- tive immunity at mucosal surfaces of the female reproductive tract stratification and integration of immune protection a- gainst the transmission of sexually transmitted infection. J Reprod Immunol, 2011, 88: 185- 194.
  • 3Wira CR, Fahey JV, Ghosh M, et al. Sex hormone regula- tion of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Re-prod Immunol, 2010, 63: 544- 565.
  • 4Okada H, Okamoto R, Tsuzuki T, et al. Progestins inhibit estradio lindueed vascular endothelial growth factor and stro- mal cell derived factor 1 in human endometrial stromal cells. Fertil Steril, 2011, 96: 786 - 791.
  • 5Winuthayanon W, Hewitt SC, Orvis GD, et al. Uterine epithelial estrogen receptor a is dispensable for proliferation but essential for complete biological and biochemical respon- ses. Proc Natl Acad Sci USA, 2010, 107: 19272- 19277.
  • 6Gortzak- Uzan L, Jimenez W, Nofech - Mozes S, et al. Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: is it time to change the gold standard? Gynecol Oncol, 2010, 116: 28-32.
  • 7Silva CS, Michelin MA, Etchebehere MR, et al. Local lym- phocytes and nitric oxide synthase in the uterine cervical stro- ma of patients with grade Ⅲ cervical intraepithelial neoplasia. Clinics (SaoPaulo), 2010, 65: 575-581.
  • 8Fukui Am Matsueda S, Kawano K, et al. Identification of B cell epitopes reactive to human papillomavirus type - 16L1 - derived peptides. VirolJ, 2012, 9: 199.
  • 9Iwasaki A. Antiviral immune responses in the genital tract: clues for vaccines. Nat Rev Immunol, 2010, 10: 699 - 711.
  • 10Naz RK. Female genital tract immunity: distinct immuno logical challenges for vaccine development. J Reprod Immu- nol, 2012, 93: 1-8.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部